Evaluate TNGX stock safety — financial health, volatility, institutional backing, and risk factors.

What are the risks of investing in TNGX? | Glauxie AI

Q: What are the risks of investing in TNGX?

Tango Therapeutics, Inc. (TNGX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Malte Peters. Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein... Employees: 200,000.

Q: How much debt does TNGX have?

Review TNGX total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Q: Is TNGX a good long-term investment?

Evaluate TNGX as a long-term investment using fundamental scores, growth metrics, and risk assessment.

What are the risks of investing in TNGX?

🦉

Tango Therapeutics, Inc. (TNGX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOMalte Peters

Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine...

Key Executives

Name	Title
Adam S. Crystal	President of Research & Development
Alan Ashworth	Founder & Member of Scientific Advisory Board
Antoni Ribas	Founder & Member of Scientific Advisory Board
Barbara L. Weber	Founder & Executive Chair
Daniella Beckman	Chief Financial Officer
Elizabeth Pingpank Hickin	Vice President of IR & Corporate Communications

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

TNGX Profile Financials

Is TNGX stock safe? How much debt does TNGX have? Is TNGX a good long-term investment?